Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a pathology that is likely directly impacted by Cx43 expression and phosphorylation; ARVC patients experience a loss of desmosomes, a specialized cell–cell junction [58,59,60]. Here, GJA1 is linked to arrhythmogenic right ventricular cardiomyopathy.